International Clinical Trial: Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296328) titled 'Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter' on Dec. 18, 2025.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: NYU Langone Health

Condition: Stuttering

Intervention: Drug: Psilocybin

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: January 15, 2026

Target Sample Size: 25

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07296328

Published by HT Digital Con...